DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide (nine amino acids) studied for its potential to promote deep, restorative delta-wave sleep. It is frequently investigated in integrative and functional medicine for its role in stress resilience, hormone regulation, and pain modulation. [1, 2, 3, 4]

While it occurs naturally in the hypothalamus, DSIP is not currently FDA-approved for human treatment, and rigorous large-scale clinical trials are limited. [1, 2, 3]

Key aspects of DSIP include:

• Mechanism: Research suggests it interacts with neurotransmitters to help normalize circadian rhythms and modulate the stress response, often lowering stress-related cortisol. [1, 2, 3]

• Administration: It is typically prepared by compounding pharmacies (where it is known as Emideltide) and administered via subcutaneous injection, usually in the evening. [1]

• Regulatory Status: The FDA actively reviews its compounding status. Online products labeled "for research only" lack quality control and carry significant legal and safety risks. [1]

  
  

Anyone considering using DSIP should do so only under the direct supervision of a qualified healthcare provider. For a deeper look at the science and legal details, explore the comprehensive ⁠Rite Aid DSIP Guide or read the ⁠Innerbody DSIP Rundown. [1]

This product for research use only.